3913 related articles for article (PubMed ID: 7245026)
1. Regional lymph node dissection for malignant melanoma of the extremities.
Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N
Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026
[TBL] [Abstract][Full Text] [Related]
2. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
3. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
4. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
5. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
6. The tumor biology of melanoma nodal metastases.
Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
[TBL] [Abstract][Full Text] [Related]
7. Selective use of wide excision with elective lymph node dissection for malignant melanoma.
Fortner JG; Rosen PP; Maclean BJ
Pathol Annu; 1985; 20 Pt 1():239-46. PubMed ID: 3991238
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
11. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
Allan CP; Hayes AJ; Thomas JM
ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the management of metastatic melanoma to regional lymphatic basins.
Mack LA; McKinnon JG
J Surg Oncol; 2004 Jul; 86(4):189-99. PubMed ID: 15221926
[TBL] [Abstract][Full Text] [Related]
14. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
17. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
Kjaer BK; Knudsen MA; Dahlstrøm KK
Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
[TBL] [Abstract][Full Text] [Related]
19. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
[TBL] [Abstract][Full Text] [Related]
20. Elective and therapeutic regional lymph node dissection for cutaneous malignant melanoma: experience of the British Columbia Cancer Agency, 1972 to 1981.
Carmichael VE; Robins RE; Wilson KS
Can J Surg; 1992 Dec; 35(6):600-4. PubMed ID: 1458385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
